论文部分内容阅读
目的对应用输血方式对患有肿瘤疾病患者实施辅助治疗的临床效果进行研究。方法选择驻马店市中心医院收治的患有肿瘤疾病患者144例,随机分为甲乙丙三组,平均每组48例。在常规肿瘤手术方案基础上,甲组研究对象不输入血液,乙组研究对象输入常规悬浮红血液,丙组研究对象输入去白细胞血液。对比三组肿瘤疾病手术治疗后出现感染的人数、在肿瘤疾病手术治疗后的切口愈合时间、输血不良反应率。结果甲组研究对象肿瘤疾病手术治疗后出现感染的人数明显少于乙丙两组,丙组研究对象肿瘤疾病手术治疗后出现感染的人数明显少于乙组,组间差异显著(P<0.05);甲组研究对象在肿瘤疾病手术治疗后的切口愈合时间明显短于乙丙两组,丙组研究对象在肿瘤疾病手术治疗后的切口愈合时间明显短于乙组,组间差异显著(P<0.05);丙组输血不良反应率明显低于乙组,组间差异显著(P<0.05)。结论应用输入去白细胞血液方式对患有肿瘤疾病患者实施辅助治疗的临床效果非常明显。
Objective To study the clinical effects of adjuvant therapy on patients with tumor diseases by means of blood transfusion. Methods 144 cases of patients with tumor diseases admitted to Zhumadian Central Hospital were randomly divided into three groups, 48 cases in each group. On the basis of routine tumor surgery program, subjects in group A did not enter blood, subjects in group B received conventional suspended red blood, and subjects in group C entered leukocyte blood. The number of patients who developed infection after surgical treatment of three groups of tumor diseases was compared with the wound healing time after surgical treatment of tumor diseases and the rate of adverse transfusion reactions. Results In group A, the number of patients with tumor disease after operation was significantly less than that in group B and C. The number of patients infected with tumor disease in group C after operation was significantly less than that in group B (P <0.05) ; Group A study in surgical treatment of tumor incision healing time was significantly shorter than the two groups of ethylene and propylene, C group of patients in the surgical treatment of tumor disease incision healing time was significantly shorter than Group B, significant difference between groups (P < 0.05). The adverse reaction rate of transfusion in group C was significantly lower than that in group B (P <0.05). Conclusions The clinical effect of adjuvant therapy on patients with oncological diseases applying the leukocyte transfusion method is very obvious.